Skip to content

Qiagen NV

US · QGEN #1551 by market cap Listed 1970
44.79 -0.86 -1.88%
Live - 5344 symbols - heartbeat 378s ago · 2026-10-08 05:30
Pre-market 44.50 -0.65%
After-hours 44.79 0.00%
Overnight 44.75 -0.09%
Market cap
9.25B
P/B
2.75
EPS
1.94
Reader sentiment Are you bullish or bearish on QGEN?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership fell 6.1 percentage points.

Institutional ownership

Held by institutions
76.00% -6.10pp
Institutions
528 +1
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund52.83%
Hedge Fund9.90%
Public Company7.31%
Private Company2.42%
Sovereign Wealth Fund1.81%
Government Pension Fund1.16%
Individual/Insider0.62%
Insurance Company0.34%
VC/PE Fund0.16%
Other23.45%

Top holders as of 2026-09-24

BlackRock 9.59% · 19.83M sh
T. Rowe Price Group, Inc. 4.38% · 9.05M sh
Vanguard Capital Management, LLC 3.89% · 8.05M sh
Principal Global Investors, LLC 3.22% · 6.65M sh
UBS Asset Management 2.59% · 5.36M sh
EARNEST Partners, LLC 2.21% · 4.57M sh
Morgan Stanley 1.95% · 4.03M sh
Amundi Asset Management 1.78% · 3.69M sh
Norges Bank Investment Management 1.73% · 3.58M sh
Marshall Wace LLP 1.69% · 3.49M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

5 filings tracked · 0 buys · 5 sells

NameRoleStake
Thierry Bernard CEO, MD & Member of Management Board 0.21%
Roland Sackers CFO, MD & Member of Management Board 0.18%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2025-08-14 Roland Sackers CFO, MD & Member of Management Board Intent to Sell (Form 144) -29,851 $51.80
2025-08-14 Thierry Bernard CEO, MD & Member of Management Board Intent to Sell (Form 144) -23,750 $51.37
2025-08-13 Roland Sackers CFO, MD & Member of Management Board Intent to Sell (Form 144) -17,648 $51.58
2025-08-12 Roland Sackers CFO, MD & Member of Management Board Intent to Sell (Form 144) -47,500 $51.71
2024-09-10 Roland Sackers CFO, MD & Member of Management Board Intent to Sell (Form 144) -23,090 $49.80

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 05:30:53 · For reference only, not investment advice and not tailored to your situation.